Clinical

Articles

Early safety data from the RELARC trial showed complete mesocolic excision doesn’t increase intraoperative and postoperative complications of laparoscopic right hemicolectomy compared with D2 dissection when done by an experienced surgeon.

Complete Mesocolic Excision is a Safe Option in Laparoscopic Right Hemicolectomy

A new imaging technique that pairs acoustic resolution photoacoustic microscopy co-registered with ultrasound and an artificial intelligence neural network was proven feasible for use in detecting residual tumor tissue in patients with rectal cancer.

Photoacoustic Microscopy With Ultrasound Technology Is Feasible for Sensing Residual Rectal Tumors Following Surgery 

Videos

Experts focus in on optimizing the use of minimal residual disease as a tool to guide decision making in the adjuvant setting for patients at risk for recurrence with colorectal cancer.					

MRD and Decision-Making in Early Stage Colorectal Cancer 					

Based on a single-institution study, investigators were able to correlate outcomes for unresectable colorectal liver metastases with the addition of hepatic arterial infusion pump therapy to systemic therapy to the presence of a mutation in KRAS. 

KRAS Mutations in Unresectable Colorectal Liver Metastases Linked to Reduced Response Rates 

During Colorectal Cancer Awareness month, CancerNetwork® sat down with Dorothy Dulko, PhD, to discuss social determinants of cancer. 

Dorothy Dulko, PhD, on Social Determinants of Developing Colorectal Cancer

Phyllis Morgan, PhD, sat down with CancerNetwork® to discuss health disparities during Colorectal Cancer Awareness Month. 

Phyllis Morgan on Health Disparities in Patients At Risk for Developing Colorectal Cancer

“Emerging evidence supports a possible role for overall dietary patterns that, in totality, emphasize habitually consuming fruits, vegetables, grains, and low-fat dairy and reducing red meat and alcohol intake,” wrote the study authors.

Study Identifies Associations Between Low CRC Risk and Prudent Dietary Patterns

A pooled analysis of 2 cohort studies suggested that individuals who began using aspirin before age 70 years and continued using the agent later in life had a reduced risk of colorectal cancer.

Aspirin Use Beginning Before and Continuing After Age 70 Reduces Risk of CRC

“As the current work is the largest ever published on adjuvant [fluoropyrimidine; FP] for patients with MSI stage III [colon cancer], it suggests that FP alone should not be recommended as adjuvant treatment for these patients,” wrote the study authors, who were led by Romain Cohen, MD, PhD.

Study Suggests Oxaliplatin-Fluoropyrimidine Combo To Be Standard-of-Care Adjuvant Treatment for Stage III MSI/dMMR Colon Cancer

Investigators suggested that findings across different clinics can help inform future implementation of the Colorectal Cancer Control Program (CRCCP).

Colorectal Cancer | Topics